Shares of Cardinal Health, Inc. (NYSE:CAH – Get Rating) have received an average recommendation of "Moderate Buy" from the twelve research firms that are currently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $70.20.
Several equities analysts recently commented on CAH shares. Credit Suisse Group upped their target price on Cardinal Health from $56.00 to $64.00 and gave the company a "neutral" rating in a research note on Friday, August 12th. StockNews.com raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 12th. UBS Group boosted their price target on Cardinal Health from $61.00 to $78.00 and gave the stock a "buy" rating in a research note on Monday, August 29th. Robert W. Baird upped their price objective on Cardinal Health from $57.00 to $73.00 and gave the company a "neutral" rating in a research note on Friday, August 12th. Finally, Cowen increased their price target on Cardinal Health from $59.00 to $72.00 and gave the stock a "market perform" rating in a research report on Tuesday, August 16th.
Get
Cardinal Health alerts:
Cardinal Health Price Performance
CAH opened at $67.79 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.57 and a debt-to-equity ratio of 5.33. The firm has a market cap of $18.47 billion, a price-to-earnings ratio of 10.18, a PEG ratio of 1.48 and a beta of 0.77. The stock's 50-day moving average price is $66.14 and its 200 day moving average price is $59.76. Cardinal Health has a 12-month low of $45.85 and a 12-month high of $72.28.
Cardinal Health (NYSE:CAH – Get Rating) last released its quarterly earnings results on Thursday, August 11th. The company reported $1.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.17 by ($0.12). Cardinal Health had a positive return on equity of 568.57% and a negative net
margin of 0.51%. The firm had revenue of $47.10 billion for the quarter, compared to analysts' expectations of $44.82 billion. During the same quarter in the prior year, the business earned $0.77 EPS. The company's quarterly revenue was up 10.6% compared to the same quarter last year. As a group, sell-side analysts expect that Cardinal Health will post 5.27 earnings per share for the current year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Saturday, October 15th. Stockholders of record on Monday, October 3rd will be issued a $0.4957 dividend. The ex-dividend date of this dividend is Friday, September 30th. This represents a $1.98 dividend on an annualized basis and a dividend yield of 2.92%. Cardinal Health's payout ratio is 29.73%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in CAH. Federated Hermes Inc. lifted its stake in Cardinal Health by 1.8% in the 2nd quarter. Federated Hermes Inc. now owns 2,808,710 shares of the company's stock valued at $146,811,000 after purchasing an additional 50,660 shares during the last quarter. Amundi lifted its stake in Cardinal Health by 880.8% in the 2nd quarter. Amundi now owns 5,043,836 shares of the company's stock valued at $272,619,000 after purchasing an additional 4,529,560 shares during the last quarter. Redhawk Wealth Advisors Inc. lifted its stake in Cardinal Health by 63.4% in the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 14,094 shares of the company's stock valued at $737,000 after purchasing an additional 5,467 shares during the last quarter. Prelude Capital Management LLC bought a new position in Cardinal Health in the 2nd quarter valued at approximately $382,000. Finally, Stock Yards Bank & Trust Co. bought a new position in shares of Cardinal Health during the second quarter valued at $333,000. Institutional investors and hedge funds own 85.07% of the company's stock.
Cardinal Health Company Profile
(Get Rating)
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Get a free copy of the StockNews.com research report on Cardinal Health (CAH)
- Humana Proves Vertically Integrated Healthcare Works
- This Small-Cap Healthcare Name Is Outperforming Its Index
- 2 Casino Stocks Worth Taking a Look At
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
